5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin ...
David Por joins the firm’s Paris team as partner | New hire brings two decades of experience, including in healthcare and ...
The former USPTO director has filed her first amicus brief since rejoining private practice, arguing that instructions issued ...
Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v ...
2 January 2024 District judge ruled in favour of Regeneron confirming patent infringement by Mylan | Court recognised Mylan's ...
Nominations open as D&I values face growing backlash on both sides of the pond | Research shows equality efforts result in ...
20 October 2022 Commission overturns one ALJ finding but affirms all others, agreeing that Wuhan Healthgen infringed ...
24 January 2025 New recruit brings expertise in developing and prosecuting complex patent portfolios for small molecule drug products | Partner joins from New York law firm Fenwick & West.